Aktis Oncology, Inc.
AKTS
$25.00
$0.281.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -31.75% | -21.05% | -20.62% | ||
| Total Depreciation and Amortization | 34.82% | -6.19% | 14.05% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -12.19% | 534.35% | 132.63% | ||
| Change in Net Operating Assets | 105.40% | -660.87% | 148.31% | ||
| Cash from Operations | 15.08% | -59.06% | 7.45% | ||
| Capital Expenditure | 31.93% | 55.37% | 18.91% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -1,294.22% | 118.31% | 70.23% | ||
| Cash from Investing | -1,408.15% | 116.24% | 74.55% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -99.95% | 131,609.30% | -100.00% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 100.00% | -119.71% | 100.00% | ||
| Cash from Financing | -99.95% | 43,823.70% | 100.00% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -186.61% | 334.33% | 146.38% | ||